In-Depth: The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction. The results of the spironolactone factorial AHA Conference Repository

American Heart Association

Final ID:

In-Depth: The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction. The results of the spironolactone factorial

Jolly, Sanjit ( HAMILTON HEALTH SCIENCES , Hamilton , Ontario , Canada )
D'entremont, Marc-andre ( McMaster University , Hamilton , Ontario , Canada )

Author Disclosures:

Sanjit Jolly:

DO have relevant financial relationships

Marc-Andre d'Entremont:

DO NOT have relevant financial relationships

Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Late-Breaking Science: In-Depth with CLEAR SYNERGY

Monday, 11/18/2024 , 09:45AM - 10:30AM

Late-Breaking Science In-Depth

More abstracts from these authors:

Mineralocorticoid receptor antagonist in patients with acute myocardial infarction: An updated systematic review and meta-analysis of randomized trials

D'entremont Marc-andre, Montalescot Gilles, Zannad Faiez, Beygui Farzin, Pitt Bertram, Jolly Sanjit, Cheema Zain, Chauhan Ashwin, Kedev Sasko, Cornel Jan, Stankovic Goran, Moreno Raul, Storey Robert, Bossard Matthias

the CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction. The results of the spironolactone factorial.

Jolly Sanjit